Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126992692 | 12699269 | 2 | F | 2016 | 20160830 | 20160830 | 20160907 | EXP | US-ENDO PHARMACEUTICALS INC.-2016-005260 | ENDO | 63.96 | YR | M | Y | 98.52000 | KG | 20160907 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126992692 | 12699269 | 1 | PS | PREDNISONE TABLETS | PREDNISONE | 1 | Oral | N | UNKNOWN | 40256 | 10 | MG | TABLETS | QD | |||||
| 126992692 | 12699269 | 2 | SS | PREDNISONE TABLETS | PREDNISONE | 1 | Oral | N | UNKNOWN | 40256 | 20 | MG | TABLETS | QD | |||||
| 126992692 | 12699269 | 3 | SS | PREDNISONE TABLETS | PREDNISONE | 1 | Unknown | N | UNKNOWN | 40256 | TABLETS | ||||||||
| 126992692 | 12699269 | 4 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 0 | 80 | MG | SOLUTION | QD | |||||||
| 126992692 | 12699269 | 5 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | 0 | ||||||||||||
| 126992692 | 12699269 | 6 | C | OPANA ER | OXYMORPHONE HYDROCHLORIDE | 1 | Oral | 201655 | 10 | MG | TABLETS | Q12H | |||||||
| 126992692 | 12699269 | 7 | C | MONTELUKAST SODIUM TABLETS 10MG | MONTELUKAST SODIUM | 1 | Oral | 91576 | 10 | MG | TABLETS | ||||||||
| 126992692 | 12699269 | 8 | C | ARMOUR THYROID | THYROID, PORCINE | 1 | Oral | 0 | 120 | MG | TABLETS | QD | |||||||
| 126992692 | 12699269 | 9 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 0 | 100 | MG | TABLETS | QD | |||||||
| 126992692 | 12699269 | 10 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | Oral | 0 | 100 | MG | TABLETS | QD | |||||||
| 126992692 | 12699269 | 11 | C | GLIPIZIDE TABLETS 10MG | 2 | Oral | 74378 | 15 | MG | TABLETS | |||||||||
| 126992692 | 12699269 | 12 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 0 | 50 | MG | TABLETS | QD | |||||||
| 126992692 | 12699269 | 13 | C | STOOL SOFTENER | DOCUSATE CALCIUM | 1 | Oral | 0 | UNKNOWN | ||||||||||
| 126992692 | 12699269 | 14 | C | LACTULOSE ORAL SOLUTION | LACTULOSE | 1 | Oral | 120-160 MG | 75993 | SOLUTION | |||||||||
| 126992692 | 12699269 | 15 | C | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 0 | INHALATION POWDER |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126992692 | 12699269 | 1 | Asthma |
| 126992692 | 12699269 | 4 | Thrombosis prophylaxis |
| 126992692 | 12699269 | 5 | Deep vein thrombosis |
| 126992692 | 12699269 | 6 | Product used for unknown indication |
| 126992692 | 12699269 | 7 | Product used for unknown indication |
| 126992692 | 12699269 | 8 | Product used for unknown indication |
| 126992692 | 12699269 | 9 | Product used for unknown indication |
| 126992692 | 12699269 | 10 | Product used for unknown indication |
| 126992692 | 12699269 | 11 | Product used for unknown indication |
| 126992692 | 12699269 | 12 | Product used for unknown indication |
| 126992692 | 12699269 | 13 | Faeces hard |
| 126992692 | 12699269 | 14 | Product used for unknown indication |
| 126992692 | 12699269 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126992692 | 12699269 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126992692 | 12699269 | Arthralgia | |
| 126992692 | 12699269 | Capillary fragility | |
| 126992692 | 12699269 | Cardiac disorder | |
| 126992692 | 12699269 | Cataract | |
| 126992692 | 12699269 | Condition aggravated | |
| 126992692 | 12699269 | Contusion | |
| 126992692 | 12699269 | Dry skin | |
| 126992692 | 12699269 | Hyperglycaemia | |
| 126992692 | 12699269 | Musculoskeletal pain | |
| 126992692 | 12699269 | Osteoporosis | |
| 126992692 | 12699269 | Pain in extremity | |
| 126992692 | 12699269 | Peripheral vascular disorder | |
| 126992692 | 12699269 | Skin atrophy | |
| 126992692 | 12699269 | Synovitis | |
| 126992692 | 12699269 | Undifferentiated connective tissue disease | |
| 126992692 | 12699269 | Vitamin D deficiency |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126992692 | 12699269 | 1 | 2016 | 0 | ||
| 126992692 | 12699269 | 2 | 20160427 | 0 | ||
| 126992692 | 12699269 | 3 | 2001 | 0 | ||
| 126992692 | 12699269 | 4 | 201512 | 0 |